Prevalence of Acb and non-Acb complex in elderly population with urinary tract infection (UTI)

References

• Turton JF, Shah J, Ozongwu C. Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species. J Clin Microbiol. 2010;48:1445–1449.
   Google Scholar
• Vaneechoutte M, Dijkshoorn L, Tjernberg I. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol. 1995;33:11–15.
   Google Scholar
• Bérézin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9:148–165.
   Google Scholar
• Falagas ME, Karveli EA, Kelesidis I, et al. Community acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis. 2007;26:857–868.
   Google Scholar
• Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538–582.
   Google Scholar
• Wasnik DD, Tumane PM. Prevalence and antibacterial susceptibility pattern of UrinaryTract Infection Causing Human Pathogenic Bacteria. Asian J Biomed Pharma Sci. 2012;2(15):1–3.
   Google Scholar
• Richet H, Fournier PE. Nosocomial infections caused by Acinetobacter baumannii: A major threat worldwide. Infect Control Hosp Epidemiol. 2006;27:645–646.
   Google Scholar
• Ecker JA, Massire C, Hall TA, et al. Identification for Acinetobacter species and genotyping of acinetobacterbaumanii by multiplex PCR and mass spectrometry. J Clin Microbiol.2006;44(8):2921–2932.
   Google Scholar
• Siegel RE. Emerging gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences. Respir Care. 2008;53(4):471–479.
   Google Scholar
• Perez F, Hujer AM, Hujer KM, et al. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(10):3471–3484.
   Google Scholar
• Mortensen BL, Skaar EP. Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection. Cell Microbiol. 2012;14(9):1336–1344.
   Google Scholar
• Wong TH, Tan BH, Ling ML, et al. Multi-resistant Acinetobacter baumannii on a burns unit—clinical risk factors and prognosis. Burns. 2002;28:349–357.
   Google Scholar
• Furuno JP, Hebden JN, Standiford HC. Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility. Am J Infect Control. 2008;36:468–471.
   Google Scholar
• Longo F, Vuotto C, Donelli G. Biofilm formation in Acinetobacter baumannii. New Microbiol. 2014;37:119–127.
   Google Scholar
• Abbassi M, Rahbar M, Hekmat Yazdi S, et al. Evaluation of the 10th external quality assessment scheme results in clinical microbiology laboratories in Tehran and districts. East Mediter Health J. 2006;12:310–315.
   Google Scholar
• Suresh K, Chandrashekara S. Sample size estimation and power analysis for clinical research studies. J Hum Reprod Sci. 2012;5:7–13.
   Google Scholar
• ICMR guidelines. Indian council of medical research national ethical guidelines for biomedical and health research involving human participants. New Delhi (India): Indian Council of Medical Research (ICMR). 2012.
   Google Scholar
• Prashanth K, Badrinath S. Simplified phenotypic tests for the identification of Acinetobacter sp., and their antimicrobial susceptibility status. J Med Microbiol. 2000;49:773–778.
   Google Scholar
• Forbes BA, Sahm DF, Weissfeld AS, editors. Bailey and Scott’s Diagnostic Microbiology. 10th ed. St. Louis: MO, Mosby; 1998.
   Google Scholar
• Elhabibi T, Ramzy S. Effect of Antibiotic Combinations on the Sensitivity of Carbapenem Resistant Acinetobacter baumannii Strains. J Microb Biochem Technol. 2017;9:132–137.
   Google Scholar
• Pragash DS, Smiline Girija AS, Sekar U, et al. Uropathogens and diabetes mellitus – A perspective. IOSR J Dent Med Sci. 2017;16(5):29–32.
   Google Scholar
• Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in healthcare facilities. Clin Infect Dis. 2006;42:692–699.
   Google Scholar
• Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect. 2009;73:355–363.
   Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–317.
   Google Scholar
• Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197:1079–1081.
   Google Scholar
• Lona Mody KE, Gibson AH, Katherine Prenovost SE, et al. Prevalence of and risk factors for multidrug-resistant Acinetobacter baumannii Colonization among high-risk nursing home residents. Infect Control Hosp Epidemiol. 2015;36(10):1155–1162.
   Google Scholar
• Tjernberg I. Antimicrobial susceptibility of Acinetobacter strains identified by DNA-DNA hybridization. APMIS. 1990;98:320–326.
   Google Scholar
• Gerner-Smidt P, Tjernberg I, Ursing J. Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol. 1991;29:277–282.
   Google Scholar
• Higgins PG, Wisplinghoff H, Krut O, et al. A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. Clin Microbiol Infect. 2007;13:1199–1201.
   Google Scholar